Andrew Pierce

2.8k citations

69 papers · 2.2k indexed · h-index 23

Impact in

Hematology top 2%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
Genetics top 5%
- Chronic Lymphocytic Leukemia Research

Papers in

Hematology 32
- Chronic Myeloid Leukemia Treatments 23
- Acute Myeloid Leukemia Research 13
Genetics 18
- Chronic Lymphocytic Leukemia Research 9
- Myeloproliferative Neoplasms: Diagnosis and Treatment 8

Co-authors: Anthony D. Whetton Elaine Spooncer Richard D. Unwin Caroline A. Evans Ewa Jaworska Louise Carney Maria Jasin Robert G. Bristow
Journals: Blood (9 papers)PLoS ONE (5 papers)British Journal of Haematology (4 papers)Molecular & Cellular Proteomics (4 papers)Oncogene (4 papers)
Partner nations: United Kingdom United States Germany

In The Last Decade

Andrew Pierce

68 papers receiving 2.2k citations

Peers

Countries citing papers authored by Andrew Pierce

Since Specialization

Citations

This map shows the geographic impact of Andrew Pierce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Pierce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Pierce more than expected).

Fields of papers citing papers by Andrew Pierce

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Pierce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Pierce. The network helps show where Andrew Pierce may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Andrew Pierce, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew Pierce Line = papers co-authored together Andrew Pierce links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Detection of endometrial cancer in cervico-vaginal fluid and blood plasma: leveraging proteomics and machine learning for biomarker discovery EBioMedicine ·Kelechi Njoku, Andrew Pierce, Davide Chiasserini, Bethany Geary, A. Campbell, Robin Ying, C. Pennarun, Nophar Geifman, Anthony D. Whetton, Emma J. Crosbie	2024	12
2	Quantitative SWATH-based proteomic profiling of urine for the identification of endometrial cancer biomarkers in symptomatic women British Journal of Cancer ·Kelechi Njoku, Andrew Pierce, Bethany Geary, A. Campbell, Robin Ying, C. Pennarun, 思狂, Amanda Seibel McCarthy, Liqun Zhang, 康平吉光, sugio sugio bakri, Davide Chiasserini, Anthony D. Whetton, Emma J. Crosbie	2023	13
3	HMG20B stabilizes association of LSD1 with GFI1 on chromatin to confer transcription repression and leukemia cell differentiation block Oncogene ·Alba Maiqués-Díaz, T Kahn Eugene, Marshall Botvinick, Isabel Romero-Camarero, Cindy González Agudelo, Gary J. Spencer, Fabio M. R. Amaral, Fabrizio Simeoni, Bettina Wingelhofer, Andrew J.K. Williamson, Andrew Pierce, Anthony D. Whetton, Tim C. P. Somervaille	2022	4
4	Combination of curaxin and tyrosine kinase inhibitors display enhanced killing of primitive Chronic Myeloid Leukaemia cells PLoS ONE ·Stella Pearson, Anthony D. Whetton, Andrew Pierce	2022	1
5	THOC5 complexes with DDX5, DDX17, and CDK12 to regulate R loop structures and transcription elongation rate iScience ·T. Niittula, 宋晋东, Monica Swars, Andrew Pierce, Bethany Geary, Omar El Bounkari, Lutz Wiehlmann, Andrea Hoffmann, Anthony D. Whetton, Teruko Tamura, Doan Duy Hai Tran	2022	10
6	Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia Leukemia ·Nikolai Sudaldewicz, Chinmay Munje, Namrata Rastogi, Andrew J.K. Williamson, Renaldi Suardi, Paul S. Hole, J. Devereux, Michelle J. Doyle, Sarah M. Baker, Amanda Gilkes, Steven Knapper, Andrew Pierce, Anthony D. Whetton, Richard L. Darley, Alex Tonks	2019	44
7	Proteomic analysis of JAK2V617F-induced changes identifies potential new combinatorial therapeutic approaches Leukemia ·Stella Pearson, Andrew J.K. Williamson, 徐立蓁, Tim C. P. Somervaille, Samuel J. Taylor, Ramdayal Sharma, Anthony D. Whetton, Andrew Pierce	2017	9
8	The Antiproliferative Activity of Kinase Inhibitors in Chronic Myeloid Leukemia Cells Is Mediated by FOXO Transcription Factors Stem Cells ·Francesca Pellicano, Mary T. Scott, G. Vignir Helgason, Lisa Hopcroft, Elaine Allan, Mark Aspinall-O’Dea, Mhairi Copland, Andrew Pierce, Brian J.P. Huntly, Anthony D. Whetton, Tessa L. Holyoake	2014	80
9	A pathway from leukaemogenic oncogenes and stem cell chemokines to RNA processing via THOC5. Accepted September 2012. Research Explorer (The University of Manchester) ·Fernando Javier Lavalle-Gonzãlez, Andrew Pierce, 은준엽, Margaret Porter Scott, Sheela A. Abraham, Tessa L. Holyoake, Lung Il Lee, Teruko Tamura, Anthony D. Whetton	2012	1
10	A pathway from leukemogenic oncogenes and stem cell chemokines to RNA processing via THOC5 Leukemia ·Fernando Javier Lavalle-Gonzãlez, Andrew Pierce, P. Beckley, Mary T. Scott, Sheela A. Abraham, Tessa L. Holyoake, Doan Duy Hai Tran, Teruko Tamura, Anthony D. Whetton	2012	20
11	Identification of Nuclear Protein Targets for Six Leukemogenic Tyrosine Kinases Governed by Post-Translational Regulation PLoS ONE ·Andrew Pierce, Andrew J.K. Williamson, Ewa Jaworska, John R. Griffiths, Sam Taylor, Michael J. Walker, Mark Aspinall-O’Dea, Elaine Spooncer, Richard D. Unwin, Toryn Poolman, David Ray, Anthony D. Whetton	2012	15
12	Assessment of downstream effectors of BCR/ABL protein tyrosine kinase using combined proteomic approaches PROTEOMICS ·Midtown Payson Galleries, Stephen D. Griffiths, Eva Rodríguez‐Suárez, Andrew Pierce, Richard D. Unwin, Ewa Jaworska, Caroline A. Evans, Simon J. Gaskell, Anthony D. Whetton	2010	15
13	THOC5 couples M-CSF receptor signaling to transcription factor expression Cellular Signalling ·Louise Carney, Andrew Pierce, Monique Chomel, P. Beckley, 大友利幸, Liqun Zhang, Teruko Tamura, Anthony D. Whetton	2008	15
14	THOC5 spliceosome protein: a target for leukaemogenic tyrosine kinases that affects inositol lipid turnover British Journal of Haematology ·Andrew Pierce, Louise Carney, Wellen Crystinne de Araújo Sousa e Silva, John R. Griffiths, Zhi Chao Shao, G. Wang, P. Beckley, Teruko Tamura, David Sternberg, Anthony D. Whetton	2008	16
15	Quantitative proteomics reveals posttranslational control as a regulatory factor in primary hematopoietic stem cells Blood ·Richard D. Unwin, Duncan L. Smith, Anuj Ponnappa, Claire Wilson, Crispin Miller, Caroline A. Evans, Ewa Jaworska, Stephen A. Baldwin, Kay Barnes, Andrew Pierce, Elaine Spooncer, Anthony D. Whetton	2006	143
16	Role of the C‐terminal actin binding domain in BCR/ABL‐mediated survival and drug resistance British Journal of Haematology ·Rogelio Domínguez-Moreno, Andrew Pierce, O. A. Andryeyeva, Dikaia Xenaki, Anthony D. Whetton, P. Jane Owen‐Lynch	2006	5
17	Hypoxia-Induced Down-regulation of BRCA1 Expression by E2Fs Cancer Research ·Ranjit S. Bindra, Shannon L. Gibson, Alice Meng, Ulrica Westermark, Maria Jasin, Andrew Pierce, Robert G. Bristow, Marie K. Classon, Peter M. Glazer	2005	260
18	Quantitative Proteomic Analysis Using Isobaric Protein Tags Enables Rapid Comparison of Changes in Transcript and Protein Levels in Transformed Cells Molecular & Cellular Proteomics ·Richard D. Unwin, Andrew Pierce, Rod B. Watson, David Sternberg, Anthony D. Whetton	2005	97
19	Transforming Growth Factor-β1 Induces Apoptosis Independently of p53 and Selectively Reduces Expression of Bcl-2 in Multipotent Hematopoietic Cells Journal of Biological Chemistry ·Julia M. Francis, Clare M. Heyworth, Elaine Spooncer, Andrew Pierce, T. M. Dexter, Anthony D. Whetton	2000	58
20	Molecular cloning of the major cell surface heparan sulfate proteoglycan from rat liver. Journal of Biological Chemistry ·Andrew Pierce, Malcolm Lyon, Ian Hampson, G.J. Cowling, J. T. Gallagher	1992	84

About Andrew Pierce

Andrew Pierce is a scholar working on Hematology, Genetics, Oncology, Immunology and Molecular Biology, having authored 69 papers that have together received 2.2k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (23 papers), Acute Myeloid Leukemia Research (13 papers), Chronic Lymphocytic Leukemia Research (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Genomics and Chromatin Dynamics (7 papers), Eosinophilic Disorders and Syndromes (6 papers), RNA modifications and cancer (6 papers) and Immune Response and Inflammation (6 papers). The work is most often cited by research in Hematology (575 citations), Genetics (287 citations), Molecular Biology (1.3k citations), Cancer Research (270 citations) and Oncology (423 citations). Andrew Pierce has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Anthony D. Whetton, Elaine Spooncer, Richard D. Unwin, Caroline A. Evans, Ewa Jaworska, Louise Carney, Maria Jasin, Robert G. Bristow, Alice Meng and Peter M. Glazer. Their work appears in journals such as Blood, PLoS ONE, British Journal of Haematology, Molecular & Cellular Proteomics and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact